This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.
Bankruptcies, restructurings, clinical trial setbacks, and falling stock prices: It’s been a disconcerting week in Biotech Land. Luckily, this newsletter has arrived like a warm hug. I want to hear from you! Send me email at [email protected].
Weed for weight loss
Skye Bioscience was once a struggling, cash-starved penny stock. Today, the company is developing a treatment for obesity that was discovered through research into marijuana, and that might be additive to the GLP-1 blockbusters. Predictably, investors have taken notice.